Cardiology prior authorization at Elevance Health
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Elevance Health cardiology PA at a glance
Elevance Health reviews cardiology PA submissions against its medical policy library, with rules drawn primarily from ACC/AHA Joint Guidelines + ESC equivalents for international references. Elevance Health-specific context: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.
Documentation packet — what to send
- Diagnosis with ICD-10 (HF with reduced/preserved EF, ATTR-CM, ASCVD)
- Most recent echocardiogram with EF, strain, valvular function
- LDL on maximally-tolerated statin (for PCSK9)
- BNP/NT-proBNP
- Documented adverse effect or contraindication to step-therapy alternatives
Common denial patterns to pre-empt
Patterns observed in cardiology across payers, and where Elevance Health's book of business overlaps:
- PCSK9 inhibitors: LDL threshold + maximally-tolerated statin not met
- Tafamidis: ATTR-CM diagnosis not confirmed by scintigraphy or biopsy
- Entresto: NYHA II-IV with reduced EF documentation missing
- Anticoagulant DOAC vs warfarin step therapy
- Step therapy
Appeal angles when Elevance Health denies
- ACC/AHA guideline class I recommendation citation
- Cardiovascular outcome trial (FOURIER, PARADIGM-HF, EMPEROR, DAPA-HF) by name
- Imaging or biomarker evidence (BNP, ejection fraction, scintigraphy grade)
- Statin intolerance documentation per NLA Position Paper
Peer-to-peer prep
- Have echo with EF and the latest LDL panel open
- Quote the guideline Class I recommendation with reference number
- For PCSK9: explicitly state 'maximally tolerated statin' — payers reject 'tried and failed' wording
- For ATTR-CM: confirm whether the diagnosis was scintigraphy-based or biopsy-based — affects PA criteria
Drug-specific PA criteria at Elevance Health
Deep dives on each drug's PA criteria at Elevance Health:
Frequently asked questions
What documentation does Elevance Health need for cardiology prior authorizations?
Elevance Health's PA packet for cardiology typically includes: Diagnosis with ICD-10 (HF with reduced/preserved EF, ATTR-CM, ASCVD); Most recent echocardiogram with EF, strain, valvular function; LDL on maximally-tolerated statin (for PCSK9); BNP/NT-proBNP. ACC/AHA Joint Guidelines + ESC equivalents for international references citations strengthen the submission.
What's the turnaround at Elevance Health?
Elevance Health standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Internal appeal window if denied: 180 days.
Which cardiology drugs does Elevance Health most often PA-restrict?
Top targets in cardiology: apixaban, rivaroxaban, evolocumab, sacubitril valsartan, tafamidis. Each follows the per-drug step therapy + documentation requirements published in Elevance Health's medical policy library.
How do I prep a peer-to-peer with Elevance Health in cardiology?
Have echo with EF and the latest LDL panel open Quote the guideline Class I recommendation with reference number Have the policy URL and the patient's chart open before the call.
Generate a Cardiology PA packet
Open ApprovalHelp — generate a cardiology PA packet tailored to Elevance Health's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com